John E. Donello
140Patents
10h-index
63Co-inventors
83Inventor score
Filing activity: Sep 18, 1997 → Jan 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6136597A | RNA export element | Chemistry; Metallurgy | 59 | Expired |
| US7141597B2 | Nonsedating α-2 agonists | Chemistry; Metallurgy | 46 | Expired |
| US7345065B2 | Methods and compositions for alleviating pain | Emerging Cross-Sectional Technologies | 43 | Expired |
| US6294553A | Method for treating ocular pain | Human Necessities | 36 | Expired |
| US7276522B2 | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds | Chemistry; Metallurgy | 31 | Expired |
| US6991910B2 | High-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels | Physics | 16 | Expired |
| US6312912A | Method for identifying a CIS-acting RNA export element | Chemistry; Metallurgy | 15 | Expired |
| US8541577B2 | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators | Chemistry; Metallurgy | 11 | Active |
| US6287814A | RNA export element and methods of use | Chemistry; Metallurgy | 11 | Expired |
| US7125908B2 | Treating pain using selective antagonists of persistent sodium current | Human Necessities | 11 | Expired |
| US8658803B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Emerging Cross-Sectional Technologies | 10 | Active |
| US8993780B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Emerging Cross-Sectional Technologies | 9 | Active |
| US8492556B2 | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Chemistry; Metallurgy | 9 | Active |
| US8097644B2 | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist | Chemistry; Metallurgy | 9 | Active |
| US7977335B2 | Methods of preventing and reducing the severity of stress-associated conditions | Human Necessities | 9 | Active |
| US8580817B2 | 1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators | Chemistry; Metallurgy | 8 | Active |
| US8816076B2 | Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators | Chemistry; Metallurgy | 7 | Active |
| US8013000B2 | 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity | Chemistry; Metallurgy | 7 | Active |
| US6284469A | RNA export element and methods of use | Chemistry; Metallurgy | 7 | Expired |
| US9579307B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Emerging Cross-Sectional Technologies | 6 | Active |
| US8791161B2 | Sulfur derivatives as chemokine receptor modulators | Chemistry; Metallurgy | 6 | Active |
| US8440684B2 | Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators | Chemistry; Metallurgy | 6 | Active |
| US7964191B2 | Compositions and methods for the treatment of ophthalmic disease | Chemistry; Metallurgy | 6 | Active |
| US7767718B2 | Treating pain using selective antagonists of persistent sodium current | Human Necessities | 6 | Active |
| US8507560B2 | Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity | Human Necessities | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.